Loading...
Back to narrative

MAP: Margin Resilience And Slower Growth Expectations Will Shape Future Performance

Update shared on 15 Dec 2025

n/a
n/a
AnalystConsensusTarget's Fair Value
n/a
Loading
1Y
77.2%
7D
3.4%

Analysts have reduced their price target on Mapfre from EUR 4.15 to EUR 3.92. This reflects expectations for slower top line growth, partially offset by a modest improvement in profitability and a slightly lower future earnings multiple.

Analyst Commentary

Analysts are reassessing Mapfre's investment case in light of the lower price target, balancing an improved profitability outlook against more muted expectations for growth and valuation upside.

Bullish Takeaways

  • Bullish analysts highlight that the modest improvement in profitability supports a more resilient earnings base, which should help underpin the revised valuation despite slower growth.
  • They see the current share price as already reflecting much of the macro and sector uncertainty, suggesting limited downside risk relative to the updated price target.
  • Mapfre's diversified business mix is viewed as a stabilizing factor, providing some protection for revenue and margins across cycles and supporting medium term cash generation.
  • Operational discipline and cost control efforts are seen as key levers that could deliver upside to earnings if management executes consistently.

Bearish Takeaways

  • Bearish analysts argue that slower top line growth reduces Mapfre's ability to re rate toward higher earnings multiples, justifying a more cautious stance on valuation.
  • They see limited near term catalysts for accelerating premium growth, which could leave the stock trading in a range around the revised target.
  • Concerns remain that competitive pressures and potential claims volatility may cap margin expansion, constraining upside to the profitability outlook.
  • Some caution that, in a higher for longer interest rate environment, investors may gravitate toward peers with stronger growth profiles, weighing on Mapfre's relative performance.

Valuation Changes

  • Fair Value: Unchanged at approximately €3.92 per share, aligning with the updated analyst price target.
  • Discount Rate: Held steady at about 7.65 percent, indicating no change in the perceived risk profile or cost of capital.
  • Revenue Growth: Reduced significantly from around 75.5 percent to about 9.5 percent, reflecting a much more conservative growth outlook.
  • Net Profit Margin: Increased modestly from roughly 3.99 percent to about 4.23 percent, signaling a slight improvement in expected profitability.
  • Future P/E: Lowered slightly from about 12.18x to roughly 11.74x, pointing to a marginally more cautious valuation multiple on forward earnings.

Have other thoughts on Mapfre?

Create your own narrative on this stock, and estimate its Fair Value using our Valuator tool.

Create Narrative

Disclaimer

AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.